Clinical Trials Directory

Trials / Completed

CompletedNCT02709941

Inspiratory Muscle Strength Training for Sleep-related Breathing Disorders

Respiratory Strength Training Mitigates Hypertension and Sleep Fragmentation in Obstructive Sleep Apnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
University of Arizona · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of the current study is to investigate the effects of a novel breathing training, called inspiratory muscle strength training (IMST), on sleep patterns, breathing and blood pressure for patients diagnosed with mild, moderate and severe sleep apnea.

Detailed description

Aims of the study: 1. To determine the influence of IMST on resting blood pressure and baroreceptor sensitivity. 2. To determine the effect of IMST on sympathetic nervous system by measuring plasma cathecholamines and nerve recording (MSNA). Population: 30 subjects aged 30-75 years, who have previously been diagnosed with obstructive sleep apnea, as defined by the National Institutes of Health (National Heart Lung, and Blood Institute) will be included in this study. Study Protocol: * Pre-training assessment and overnight sleep study * 5-10 minutes each day breathing training (IMST) at home using a hand-held device for 6 weeks * Once weekly laboratory visit * Post-training assessment and overnight sleep study Pre- and post-training assessment include blood pressure measurement, body weight, neck circumference, cardiorespiratory monitoring, nerve recording, blood draw and sleep surveys.

Conditions

Interventions

TypeNameDescription
OTHERInspiratory muscle strength trainingBreathing training designed to augment inspiratory muscle strength, and thus targeted muscle groups may benefit from improved force generating capability result in improved breathing.
OTHERPlacebo

Timeline

Start date
2016-03-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2016-03-16
Last updated
2017-11-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02709941. Inclusion in this directory is not an endorsement.